Effects of heparin bridging anticoagulation on perioperative bleeding and thromboembolic risks in patients undergoing abdominal malignancy surgery

Journal of Anesthesia

Volumn 30, Issue 4, 2016, Pages 723-726

  Ono, Kazumi ^a   Hidaka, Hidekuni ^a   Koyama, Yusuke ^a   Ishii, Kenzo ^a   Taguchi, Shinya ^a   Kosaka, Mako ^a   Okazaki, Nobuki ^a   Tanimoto, Wakana ^a   Katayama, Akira ^a  

^a Fukuyama City Hospital   (Japan)

Author keywords

Bleeding; Heparin bridging anticoagulation; Malignancy surgery; Perioperative; Thromboembolism

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT;

ABDOMINAL SURGERY; ADULT; AGED; ANTICOAGULATION; ARTICLE; BILE DUCT CANCER; BLOOD TRANSFUSION; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATIVE BLOOD LOSS; PANCREAS CANCER; PERIOPERATIVE THROMBOEMBOSIS; PEROPERATIVE COMPLICATION; THROMBOEMBOLISM; THROMBOSIS PREVENTION; VERY ELDERLY; HEMORRHAGE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD TRANSFUSION; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK; THROMBOEMBOLISM;

EID: 84971612103     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-016-2187-0     Document Type: Article

References (6)

1. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R. Perioperative management of antithrombotic therapy: an atithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e326S–50S.
2. Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedual heparin bridging in patients receiving vitamin K antagonists: systemic review and meta-analysis of bleeding and thrombolic rates. Circulation. 2012;126:1630–9.
3. Steinberg BA, Peterson ED, Kim S, Thomas L, Gersh BJ, Fonarow GC, Kowey PR, Mahaffey KW, Sherwood MW, Chang P, Piccini JP, Ansell J. Use and outocomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation (ORBIT-AF). Circulation. 2015;131:488–94.
4. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DA, Schulman S, Turpie AGG, Hasselblad V, Ortel TL. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373:823–33.
5. Beyer-Westendorf J, Gelbricht V, Forster K, Ebertz F, Kohler C, Werth S, Kuhlisch E, Stange T, Thieme C, Daschkow K, Weiss N. Peri-operative management of novel oral antagonists in daily care: results from the prospective Dresden NOAC registry. Eur Heart J. 2014;35:888–96.
6. Ono K, Hidaka H, Koyama Y, Ishii K, Tanaka C, Taguchi S, Kimura M. Thrombotic and Bleeding Risks of Patients on Antiplatelet Therapy Undergoing Major Abdominal Malignancy Surgery (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 2016;65:341–347.